Lung cancer (LC) causes few symptoms in the earliest stages, leading to one of the highest
mortality rates among cancers. Low-dose computerised tomography (LDCT) is used to …

Liquid biopsy, a powerful non-invasive test, has been widely used in cancer diagnosis and
treatment. Platelets, the second most abundant cells in peripheral blood, are becoming one …

Lung cancer is a major cause accounting for cancer-related mortalities, with lung
adenocarcinoma (LUAD) being the most prevalent subtype. Given the high clinical and …

Thyroid cancer (TC) is one of the most common endocrine malignancies, and its incidence
has increased globally. Despite extensive research, the underlying molecular mechanisms …

Neurodegeneration in Parkinson's disease (PD) precedes diagnosis by years. Early
neurodegeneration may be reflected in RNA levels and measurable as a biomarker. Here …

High-throughput sequencing and multiomics technologies have allowed increasing
numbers of biomarkers to be mined and used for disease diagnosis, risk stratification …

Lung cancer screening programs, particularly in the UK, have shown a decrease in lung
cancer-related deaths among individuals who underwent low-dose computed tomography …

We aimed to investigate the use of free glycosaminoglycan profiles (GAGomes) and cfDNA
in plasma to differentiate between lung cancer and benign lung disease, in a cohort of 113 …

Background Circular RNAs (circRNAs) are involved in the occurrence and development of
various tumors. CircRNAs can act as competing endogenous RNAs (ceRNAs), which are …

We aimed to investigate the use of free glycosaminoglycan profiles (GAGomes) and cfDNA
in plasma to differentiate between lung cancer and benign lung disease. GAGs were …